580 results on '"Eisfeld, Ann-Kathrin"'
Search Results
2. Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)
3. Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study
4. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia
5. Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes
6. Impact of IDH1 and IDH2 mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation
7. Inequities in timely treatment (Tx) initiation for patients (pts) with acute myeloid leukemia (AML) treated in a predominantly community setting in the United States (US).
8. High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML
9. Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia
10. Racial and ethnic survival disparities in patients with haematological malignancies in the USA: time to stop ignoring the numbers
11. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/ KMT2A
12. Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)
13. Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia
14. White blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged <60 years.
15. Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutations
16. Author Correction: An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia
17. Clinical and functional significance of circular RNAs in cytogenetically normal AML
18. Acute Myeloid Leukemia Genomics: Impact on Care and Remaining Challenges
19. Disparities in acute myeloid leukemia treatments and outcomes
20. Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)
21. Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years
22. Discovery of clinically relevant fusions in pediatric cancer
23. Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement
24. A precision medicine classification for treatment of acute myeloid leukemia in older patients
25. Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21
26. Disparities in acute myeloid leukemia treatments and outcomes.
27. P583: PROGNOSTIC IMPLICATIONS OF WT1 MUTATIONS IN PATIENTS WITH DE NOVO AND RELAPSED ACUTE MYELOID LEUKEMIA IN THE ERA OF NOVEL TARGETED THERAPIES
28. P422: TARGETING THE WT1MUT-MIR-193A TRANSCRIPTIONAL AXIS WITH INT-1B3, A NOVEL LIPID NANOPARTICLE-FORMULATED MIR-193A-3P MIMIC IN ACUTE MYELOID LEUKEMIA
29. Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically
30. Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA
31. NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome
32. Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanoma
33. Association of social deprivation with survival in younger adult patients with AML: an Alliance study
34. Abstract A20: Inflammation remodels the immune microenvironment in acute myeloid leukemia
35. Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
36. Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies
37. Outcomes of Older Adults With AML Treated in Community Versus Academic Centers: An Analysis of Alliance Trials
38. Data from The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation
39. Supplementary Figure from The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation
40. Supplementary Data from The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation
41. Data from Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia
42. Data from Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia
43. Supplementary Data from Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia
44. Supplementary Tables 1 - 4, Figures 1 - 6 from Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia
45. Supplementary Materials from Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality
46. Supplementary Table S4 from Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia
47. Data from Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality
48. Supplementary Data from Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia
49. Supplemental Figures and Tables from Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality
50. Supplementary Figure 7 from Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.